These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 10749148)
1. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids. Cahlin C; Gelin J; Delbro D; Lönnroth C; Doi C; Lundholm K Cancer Res; 2000 Mar; 60(6):1742-9. PubMed ID: 10749148 [TBL] [Abstract][Full Text] [Related]
2. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors. Cahlin C; Gelin J; Andersson M; Lönnroth C; Lundholm K Int J Oncol; 2005 Oct; 27(4):913-23. PubMed ID: 16142306 [TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase inhibition in early onset of tumor growth and related angiogenesis evaluated in EP1 and EP3 knockout tumor-bearing mice. Axelsson H; Lönnroth C; Wang W; Svanberg E; Lundholm K Angiogenesis; 2005; 8(4):339-48. PubMed ID: 16400521 [TBL] [Abstract][Full Text] [Related]
4. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer. Camp ER; Yang A; Liu W; Fan F; Somcio R; Hicklin DJ; Ellis LM Clin Cancer Res; 2006 Apr; 12(8):2628-33. PubMed ID: 16638876 [TBL] [Abstract][Full Text] [Related]
5. NOS isoenzyme content in brain nuclei as related to food intake in experimental cancer cachexia. Wang W; Svanberg E; Delbro D; Lundholm K Brain Res Mol Brain Res; 2005 Apr; 134(2):205-14. PubMed ID: 15836918 [TBL] [Abstract][Full Text] [Related]
6. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors. Ohno R; Yokota A; Tanaka A; Takeuchi K J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. Konopka TE; Barker JE; Bamford TL; Guida E; Anderson RL; Stewart AG Cancer Res; 2001 Apr; 61(7):3182-7. PubMed ID: 11306506 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
9. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation. Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810 [TBL] [Abstract][Full Text] [Related]
10. Involvement of inducible isoforms of COX and NOS in streptozotocin-pancreatic damage in the rat: interactions between nitridergic and prostanoid pathway. González E; Roselló-Catafau J; Jawerbaum A; Vela J; Sinner D; Pustovrh C; White V; Xaus C; Peralta C; Gimeno MA Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):311-6. PubMed ID: 11427040 [TBL] [Abstract][Full Text] [Related]
11. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia. Cahlin C; Körner A; Axelsson H; Wang W; Lundholm K; Svanberg E Cancer Res; 2000 Oct; 60(19):5488-93. PubMed ID: 11034092 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing. Guo JS; Cho CH; Wang JY; Koo MW Eur J Pharmacol; 2006 May; 536(3):301-8. PubMed ID: 16600210 [TBL] [Abstract][Full Text] [Related]
13. Indomethacin and telomerase activity in tumor growth retardation. Lönnroth C; Andersson M; Lundholm K Int J Oncol; 2001 May; 18(5):929-37. PubMed ID: 11295037 [TBL] [Abstract][Full Text] [Related]
14. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374 [TBL] [Abstract][Full Text] [Related]
15. Evidence for cyclooxygenase activation by nitric oxide in astrocytes. Molina-Holgado F; Lledó A; Guaza C Glia; 1995 Oct; 15(2):167-72. PubMed ID: 8567068 [TBL] [Abstract][Full Text] [Related]
16. Polygonum cuspidatum, compared with baicalin and berberine, inhibits inducible nitric oxide synthase and cyclooxygenase-2 gene expressions in RAW 264.7 macrophages. Kim KW; Ha KT; Park CS; Jin UH; Chang HW; Lee IS; Kim CH Vascul Pharmacol; 2007; 47(2-3):99-107. PubMed ID: 17553752 [TBL] [Abstract][Full Text] [Related]
17. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension. Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappaB. Chun KS; Cha HH; Shin JW; Na HK; Park KK; Chung WY; Surh YJ Carcinogenesis; 2004 Mar; 25(3):445-54. PubMed ID: 14633657 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment. Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch. Payá M; García Pastor P; Coloma J; Alcaraz MJ Br J Pharmacol; 1997 Apr; 120(8):1445-52. PubMed ID: 9113364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]